Page 2 - Nvidia Bionemo News Today

Recursion Pharmaceuticals Inc. shares soared Wednesday after the drug developer said that graphics processing unit maker Nvidia Corp. invested $50 million in...

Chip giant Nvidia has invested $50 million USD in Recursion to fuel the development of its AI for drug-discovery tech, as part of a deal that will see the two US firms collaborate.

Nvidia appears to be in the early stages of another massive business transformation.

Company offering Hopper GPU systems on-prem and in cloud

Nvidia is offering a new set of cloud services, called AI Foundations, that let businesses create and use their own AI models.

Nvidia unveils DGX Cloud platform and AI foundation models for generative AI training - SiliconANGLE

Nvidia develops AI models used to accelerate protein discovery and prevent retail theft - SiliconANGLE